Clinical-stage oncology company Prescient Therapeutics Ltd has opened the first clinical site for its Phase 2a study of ...

Nasdaq leads gains US stocks edged into positive territory before Friday’s close as president Trump signalled ‘flexibility’ ...

More aggressive reduction ahead Wells Fargo expects a more aggressive 75-basis-point reduction by year-end, arguing that an ...